Octave Specialty Group, Inc.
4.75USD
+0.0300 (+0.64%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on OSG.
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 30.7M | 51.3M | 92.0M | 143.4M | 362.5M | 410.3M |
| Q1 | 9.0M | 14.0M | 17.7M | 36.8M | 68.2M | — |
| Q2 | 6.0M | 10.0M | 13.2M | 30.3M | 49.7M | — |
| Q3 | 7.0M | 15.0M | 23.1M | 36.1M | 92.4M | — |
| Q4 | 8.7M* | 12.3M | 38.0M | 40.2M* | 88.5M | — |
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 11.48 | .180 | -11.96 | -5.93 | .170 | .590 |
| Q1 | .040 | -.730 | .440 | -1.21 | -.130 | — |
| Q2 | .110 | -.290 | -.020 | -1.51 | -.330 | — |
| Q3 | 7.41 | 1.44 | -.630 | -2.35 | -.047 | — |
| Q4 | 3.83* |
Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.
Revenue to net income
| -.240 |
| -10.23 |
| -.580* |
| -.110 |
| — |
Debt level and coverage